Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Eisai
Company Monitoring Page for Eisai
latest headlines for company on cafepharma
Biopharma developments over the Christmas period
EP Vantage
Mon, 01/3/22 - 10:26 am
Tags:
Alnylam Pharmaceuticals
,
Bio-Thera Solutions
,
BioArctic
,
Biogen
,
BridgeBio Pharma
,
Daiichi Sankyo
,
Eisai
,
JNJ
,
Madrigal Pharmaceuticals
,
Merck
,
Sutro BioPharma
,
Tasly Pharmaceutical Group
Biogen-Eisai's potential Aduhelm sequel drug granted speedy review by FDA
Fierce Biotech
Tue, 12/28/21 - 10:55 am
Tags:
Biogen
,
Eisai
,
lecanemab
,
FDA
,
Aduhelm
,
fast track
,
Alzheimer's disease
Biogen, Eisai face down another Aduhelm refusal—this time from Japanese regulators
Fierce Pharma
Wed, 12/22/21 - 11:06 am
Tags:
Biogen
,
Eisai
,
Aduhelm
,
Japan
,
Alzheimer's disease
Licensing deals rack up in 2021
EP Vantage
Fri, 12/10/21 - 10:46 am
Tags:
licensing
,
GSK
,
Alector
,
Novartis
,
BeiGene
,
Pfizer
,
Arvinas
,
iTeos Therapeutics
,
Bristol Myers Squibb
,
Eisai
Eisai-Biogen Alzheimer's Drug Shows Amyloid Reduction, Disease-Modifying Effect
BioSpace
Thu, 11/11/21 - 10:55 am
Tags:
Eisai
,
Biogen
,
lecanemab
,
Alzheimer's disease
,
clinical trials
What Novartis could buy with its windfall
EP Vantage
Fri, 11/5/21 - 09:40 am
Tags:
Novartis
,
M&A
,
Roche
,
Sandoz
,
Aurinia Pharmaceuticals
,
Alnylam
,
Exelixis
,
Incyte
,
Eisai
,
Genmab
Eisai-backed trial will assess Altoida’s digital test for early Alzheimer’s
Pharmaforum
Wed, 10/20/21 - 10:08 am
Tags:
Altoida
,
Eisai
,
clinical trials
,
augmented reality
,
Alzheimer's disease
Seizing Aduhelm precedent, Biogen, Eisai get the ball rolling on another accelerated Alzheimer's approval
Endpoints
Tue, 09/28/21 - 12:07 am
Tags:
Biogen
,
Aduhelm
,
Eisai
,
Alzheimer's disease
,
FDA
,
lecanemab
FDA Action Alert: Cara/Vifor, Kadmon, BMS, Merck/Eisai
BioSpace
Mon, 08/23/21 - 11:10 am
Tags:
FDA
,
Cara Therapeutics
,
Vifor Pharma
,
Korsuva
,
Kadmon
,
belumosudil
,
Bristol Myers Squibb
,
Opdivo
,
Merck
,
Eisai
,
Keytruda
Merck's Best Seller Keytruda Racks Up Another Regulatory Win
BioSpace
Thu, 08/12/21 - 12:35 pm
Tags:
Merck
,
Keytruda
,
advanced renal cell carcinoma
,
renal cell carcinoma
,
Eisai
,
Lemvima
,
FDA
Biogen, Eisai are pushing for another accelerated Alzheimer's OK — this time for BAN2401
Endpoints
Wed, 08/4/21 - 10:55 am
Tags:
Biogen
,
Eisai
,
FDA
,
Alzheimer's disease
,
BAN2401
Biogen Partner Pushing On With Alzheimer’s Drug Despite Fracas
Bloomberg
Thu, 07/15/21 - 10:45 am
Tags:
Biogen
,
Eisai
,
Alzheimer's disease
,
lecanemab
,
BAN2401
Eisai-Biogen Alzheimer’s drug gets FDA breakthrough designation
Pharmaceutical Business Review
Thu, 06/24/21 - 10:56 am
Tags:
Eisai
,
Biogen
,
FDA
,
lecanemab
,
breakthrough status
,
Alzheimer's disease
Bristol Myers pays $650M for rights to Eisai's phase 1 ADC
Fierce Biotech
Fri, 06/18/21 - 10:11 am
Tags:
Bristol Myers Squibb
,
antibody-drug conjugate
,
MORAb-202
,
Eisai
Bristol-Myers, Eisai in up to $3.1 bln deal to develop cancer drug candidate
Reuters
Thu, 06/17/21 - 10:56 pm
Tags:
Bristol Myers Squibb
,
Eisai
,
drug development
,
cancer
When Will Lecanemab be Available to Alzheimer’s Patients?
BioSpace
Tue, 04/20/21 - 11:11 pm
Tags:
Eisai
,
lecanemab
,
BAN2401
,
Alzheimer's disease
Biogen's Aducanumab: A Look at the Drug’s History and Recent Updates
BioSpace
Sat, 03/27/21 - 12:14 pm
Tags:
Biogen
,
Eisai
,
aducanumab
,
Alzheimer's disease
Merck breathes a sigh of relief as Keytruda-Lenvima combo aces confirmatory study in endometrial cancer
Endpoints
Fri, 03/19/21 - 10:51 am
Tags:
Merck
,
FDA
,
Keytruda
,
Eisai
,
Lenvima
,
clinical trials
,
endometrial cancer
Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021
PR Newswire
Tue, 03/9/21 - 10:45 am
Tags:
Clarivate
,
Biogen
,
Eisai
,
aducanumab
,
UCB Pharma
,
bimekizumab
,
Relugolix
,
Pfizer
,
Takeda
,
Myovant
,
vericiguat
,
Bayer
,
Merck
Merck's Keytruda Plus Eisai's Lenvima Could Open New Standard of Care in Renal Cancer
BioSpace
Tue, 02/16/21 - 11:12 am
Tags:
Merck
,
ASCO GU
,
Keytruda
,
Eisai
,
Lenvima
,
renal cell carcinoma
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.